🔎 Trials Near Me

Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Wisconsin › Milwaukee

Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Milwaukee, WI keessatti

Qorannoo 15 Luukemiya Limfoositiikii Keessummaa f Milwaukee fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Namoota walitti qabaa jiraSadarkaa 3
  • UW Cancer Center at ProHealth Care, Waukesha · Miili 17 fagaatti
  • ProHealth D N Greenwald Center, Mukwonago · Miili 25 fagaatti
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • fi 9 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277231

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Namoota walitti qabaa jiraSadarkaa 3
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Namoota walitti qabaa jiraSadarkaa 2
  • The Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221500

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 1
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT03666000

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT07218510

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Namoota walitti qabaa jiraSadarkaa 4
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 4
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06876662

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT04186520

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • The Medical College of Wisconsin, Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Mud-2025 · NCT05602363

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 10-Sad-2025 · NCT03375619

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Gur-2025 · NCT06788639

Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti

Qorannoo biroo Milwaukee keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.